Dr Reddy's Laboratories launches hair loss tablets in US

Drug firm Dr Reddy's Laboratories today said it has launched it's generic Finasteride tablets used for treating male pattern hair loss in the American market.
   
The company has launched Finasteride tablets in the strength of 1 mg in the US market on January 2 following the approval of its abbreviated new drug application (ANDA) with 180 days of marketing exclusivity, Dr Reddy's Laboratories said in a statement.

Also read: Nifty flat; IT stocks nudge up; Dr Reddy's up 2.8%
   
The tablets are bioequivalent generic version of Merck Sharp & Dohme Corp, a subsidiary of Merck & Co Inc's Propecia tablets, it added. "The Propecia tablets brand has US sales of approximately USD 136 million for the most recent twelve months ending in October 2012 according to IMS Health," Dr Reddy's said.
    
The generic Finasteride tablets 1 mg of the company is available in bottle counts of 30 and 90, it added. Shares of Dr Reddy's Laboratories were today trading at Rs 1,886.80 in the afternoon trade on BSE, up 2.67 per cent from its previous close.